Virax Biolabs GroupVRAX -0.64%37 Days Inventory is 13,596.25 as of Sep. 2025, which is 3852% above its 10-year median of 344.01. GuruFocus rates VRAX with a GF Score™ of 37/100 and a GF Value™ of $1.15 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 635 Biotechnology companies, Virax Biolabs Group ranks worse than 86.77% on this metric.
The historical rank and industry rank for Virax Biolabs Group's Days Inventory or its related term are showing as below:
VRAX'
s Days Inventory Range Over the Past 10 Years
Min: 57.63 Med: 344.01 Max: 766.5
Current: 680.34
During the past 6 years, Virax Biolabs Group's highest Days Inventory was 766.50. The lowest was 57.63. And the median was 344.01.
VRAX's Days Inventory is ranked worse than 86.77% of 635
companies
in the Biotechnology industry
Industry Median: 183.23
vs VRAX: 680.34
Virax Biolabs Group's Days Inventory
increased
from Sep. 2024 (1,534.66) to Sep. 2025 (13,596.25).
It might indicate that Virax Biolabs Group's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Virax Biolabs Group's Inventory Turnover for the
six
months ended in Sep. 2025 was 0.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Virax Biolabs Group's Inventory-to-Revenue for the
six
months ended in Sep. 2025 was 37.25.
Virax Biolabs Group (NAS:VRAX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Virax Biolabs Group's Inventory Turnover for the
six
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Virax Biolabs Group's Inventory to Revenue for the
six
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Virax Biolabs Group Days Inventory Related Terms
Virax Biolabs Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Virax Biolabs Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VRAX vs BBLG, PKTX, OGEN: Days Inventory Comparison
For the Biotechnology subindustry, Virax Biolabs Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Virax Biolabs Group Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Virax Biolabs Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Virax Biolabs Group (VRAX) has a Days Inventory of 13,596.25 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Virax Biolabs Group and its competitors. This is 3852% above median its historical median of 344.01. Over the past decade, Virax Biolabs Group's Days Inventory has ranged from 57.63 to 766.50. According to the industry distribution chart, Virax Biolabs Group ranks #551 out of 635 companies in the Biotechnology industry, placing it in the top 86.8%.
Is Virax Biolabs Group's Days Inventory too high?
Virax Biolabs Group's current Days Inventory of 13,596.25 is 3852% above median its 10-year median of 344.01. Over the past 10 years, this metric has ranged from a low of 57.63 to a high of 766.50. The Biotechnology industry median Days Inventory is 183.23. Virax Biolabs Group's value of 13,596.25 is 7320.3% above this industry median. Based on the distribution chart, Virax Biolabs Group ranks #551 out of 635 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Virax Biolabs Group has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Virax Biolabs Group's Days Inventory compare to BBLG and PKTX?
According to the Biotechnology industry distribution chart, Virax Biolabs Group ranks #551 out of 635 companies for Days Inventory. This places Virax Biolabs Group in the lower half of its industry. The industry median Days Inventory is 183.23. Virax Biolabs Group's value of 13,596.25 is 7320.3% above this benchmark. Historically, Virax Biolabs Group's own Days Inventory has ranged from 57.63 to 766.50 over the past decade. While the company's 10-year median is 344.01 vs. the industry median of 183.23, Virax Biolabs Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Virax Biolabs Group's current Days Inventory of 13,596.25 is 7320.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Virax Biolabs Group and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Virax Biolabs Group's current Days Inventory is 13,596.25, which is 3852% above median its own 10-year median of 344.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virax Biolabs Group stock overvalued right now?
Based on GuruFocus' analysis, Virax Biolabs Group (VRAX) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.15, compared to a current price of $3.09 — trading 168.7% above its estimated fair value. The current Days Inventory is 13,596.25, which is 3852% above median its 10-year median of 344.01 and 7320.3% above the Biotechnology industry median of 183.23. Virax Biolabs Group's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Virax Biolabs Group (VRAX), the current Days Inventory is 13,596.25 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Virax Biolabs Group (VRAX) Overvalued in 2026?
Based on GuruFocus' analysis, Virax Biolabs Group stock appears to be overvalued.
The current stock price of $3.09 is trading 168.7% above its estimated GF Value™ of $1.15.
GuruFocus considers Virax Biolabs Group to be Significantly Overvalued.
Key valuation signals for VRAX:
Days Inventory: 13,596.25 (3852% above median its 10-year median of 344.01)
GF Value™: $1.15 vs. price of $3.09 (168.7% above fair value)
Industry Position: 7320.3% above the Biotechnology median (#551 of 635)
No single metric tells the full story. See the VRAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
37GF Score
Get the complete analysis for VRAX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRAX has been successfully added to your 
